WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Options
Query Language
Stem
Sort by:
List Length
1. (WO2013121048) NEW METHOD FOR PROGNOSING THE SURVIVAL OF PATIENTS SUFFERING FROM CHRONIC MYELOMONOCYTIC LEUKAEMIA
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2013/121048 International Application No.: PCT/EP2013/053204
Publication Date: 22.08.2013 International Filing Date: 18.02.2013
IPC:
C12Q 1/68 (2006.01)
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
Q
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1
Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
68
involving nucleic acids
Applicants: CENTRE HOSPITALIER UNIVERSITAIRE NIMES[FR/FR]; Place du professeur Robert Debré F-30000 Nîmes, FR
ACOBIOM[FR/FR]; 1682, rue de la Vaisière Cap Delta ZAC Euromédecine II F-34790 Grabels, FR
Inventors: PIQUEMAL, David; FR
JOURDAN, Eric; FR
COMMES, Thérèse; FR
BOU SAMRA, Elias; LB
Agent: FAIVRE PETIT, Frédérique; Regimbeau 20 rue de Chazelles F-75847 Paris cedex 17, FR
Priority Data:
12305187.217.02.2012EP
Title (EN) NEW METHOD FOR PROGNOSING THE SURVIVAL OF PATIENTS SUFFERING FROM CHRONIC MYELOMONOCYTIC LEUKAEMIA
(FR) NOUVEAU PROCÉDÉ DESTINÉ À PRONOSTIQUER LES CHANCES DE SURVIE DE PATIENTS SOUFFRANT D'UNE LEUCÉMIE MYÉLOMONOCYTAIRE CHRONIQUE
Abstract:
(EN) The present invention relates to a method of prognostic of the survival of human subject suffering from chronic myelomonocytic leukemia (CMML) based on the differential expression of six genes in a test sample of PBMC cells obtained from said human subject and in a control sample of normal cells, wherein said expression level indicates if the human subject from which the test sample has been obtained will have long-term or short-term survival.
(FR) La présente invention concerne un procédé destiné à pronostiquer la survie de sujets humains souffrant d'une leucémie myélomonocytaire chronique (CMML) reposant sur l'expression différentielle de six gènes dans un échantillon d'essai des cellules PBMC obtenues à partir dudit sujet humain et dans un échantillon témoin de cellules normales, ledit niveau d'expression indiquant si le sujet humain à partir duquel l'échantillon d'essai a été obtenu aura une survie à long ou à court-terme.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)